High-volume hospitals equal higher survival rates for bleeding strokes

July 11, 2002

DALLAS, July 12 - Patients are more likely to survive a stroke caused by a burst blood vessel if they are admitted to a hospital that treats these strokes more often. Yet, few patients are referred from less-experienced facilities, according to a review of inpatient mortality at California hospitals published in the July issue of Stroke: Journal of the American Heart Association.

Researchers at the University of California, San Francisco, searched admission records and discharge abstracts for subarachnoid hemorrhage (SAH) in a database of all non-federal hospitals in the state between 1990 and 1999.

Subarachnoid hemorrhage occurs when a blood vessel bursts within the weblike system of vessels and capillaries surrounding the exterior surface of the brain. SAH can cause brain damage, coma and death.

Data on 12,804 patients (62 percent female, average age 52,) admitted to 390 hospital emergency departments for SAH were examined, and outcomes were compared with each facility's annual SAH case rate.

Hospitals were divided into quartiles based on their annual SAH case rate. Those in the lowest quartile had 0-8 cases per year, while hospitals in the highest quartile saw 19-70 cases. Mortality was 49 percent in hospitals with the fewest SAH cases, and 32 percent in those with the most cases.

The correlation between mortality and treatment volume persisted even when the researchers examined multiple variables that might contribute to it. The length of stay was longer for patients at the higher-volume hospitals, and the costs were higher.

In addition, only 4.8 percent of patients at hospitals with the fewest SAH cases each year had been referred to higher-volume centers for care and treatment, the researchers found.

The study mirrors findings for other diseases, note authors Naomi Bardach, B.A., and S. Claiborne Johnston, M.D., Ph.D., assistant professor of neurology and epidemiology. Studies have shown better survival rates at higher-volume facilities for patients with other complex medical needs, including coronary artery bypass surgery, carotid endarterectomy and HIV. Policies discouraging coronary bypass procedures at lower-volume hospitals are credited for sharp declines in patient deaths in New York and Canadian hospitals, the researchers say.

Policies that encourage patient transfer to higher-volume hospitals could have a major impact in reducing mortality from SAH, the researchers conclude, although such transfers are not always feasible. Such policies may be cost-effective, but further confirmation of the benefit of transfer is required.
The study was funded in part by the National Institutes of Health.

CONTACT: For journal copies only,
please call: (214) 706-1396
For other information, call:
Bridgette McNeill: (214) 706-1135
Maggie Francis: (214) 706-1397

American Heart Association

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.